US 11806353
Methods of treating liver disorders or lipid disorders with a THR-beta agonist
granted A61KA61K31/53A61P
Quick answer
US patent 11806353 (Methods of treating liver disorders or lipid disorders with a THR-beta agonist) held by Madrigal Pharmaceuticals, Inc. expires Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Madrigal Pharmaceuticals, Inc.
- Grant date
- Tue Nov 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/53, A61P, A61P1/16, A61P3/06